文献速递乳腺技术与安全MR

MRI引导真空辅助乳腺活检对仅MRI可见病灶的诊断效能与不一致预测因素

MRI-Guided Vacuum-Assisted Breast Biopsy for MRI-Only Breast Lesions: Diagnostic Performance and Predictors of Histopathological Discordances.
PubMed 文献 · Acad Radiol · 2026-08-20

本研究回顾性分析了292例仅MRI可见乳腺病灶行MRI引导真空辅助活检(MRI-VABB)的患者,以手术和随访为参考标准评估诊断效能。总体恶性率为28.4%,组织病理学不一致率为6.5%,其中低估4.4%、假阴性2%。病灶位于外上象限以外是组织病理学不一致的独立预测因素。

要点

  • MRI-VABB对仅MRI可见乳腺病灶总体可靠,但仍有4.4%低估和2%假阴性。
  • 病灶位于外象限以外时组织病理学不一致风险显著增高(OR=3.02)。
  • 良性活检结果后仍需进行影像-病理一致性评估和MRI随访。

核心结论

  • MRI-VABB是评估仅MRI可见乳腺病灶的可靠技术,但组织病理学低估和假阴性仍可能发生,尤其见于外象限以外的病灶。
  • 良性活检结果后应进行影像-病理一致性评估和适当随访以优化患者管理。

研究设计与样本

  • 以手术病理和随访结果为参考标准评估诊断效能。

关键影像表现/征象

  • 病灶位于外象限以外与组织病理学不一致显著相关,OR=3.02,95%CI 1.09-9.79,p=0.044。
  • 病灶大小≥2cm显示不一致风险增高的趋势,但未达统计学显著,OR=2.65,95%CI 0.96-7.01,p=0.053。

诊断标准与关键数值

  • 总体恶性率为28.4%。
  • 组织病理学不一致率为6.5%(19/292),其中总体低估率为4.4%(13/292),假阴性率为2%(6/292)。
  • 6例假阴性中,2例在即时影像-病理一致性评估中发现,4例在活检后MRI随访中于7、21、35和36个月时发现。

临床应用与阅片要点

  • 对仅MRI可见乳腺病灶行MRI-VABB后,应常规进行影像-病理一致性评估。
  • 对外象限以外的病灶需提高警惕,注意低估和假阴性的可能。
  • 良性活检结果后仍需安排MRI随访以发现延迟诊断的恶性病灶。

局限性

  • 回顾性单中心研究设计本身存在选择偏倚和可推广性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate the diagnostic performance of magnetic resonance imaging (MRI)-guided vacuum-assisted breast biopsy (MRI-VABB) for breast lesions detected only on MRI versus surgery and follow-up and to identify factors associated with histopathological underestimations and false negatives (FN).

MATERIALS AND METHODS: In this retrospective single-center study, 292 breast lesions in 292 patients who underwent MRI-VABB between June 2015 and December 2024 were analyzed. Clinical, imaging, procedural, and histopathological data were collected to identify histopathological underestimations and FN.

RESULTS: Among 292 lesions that underwent MRI-VABB, the overall malignancy rate was 28.4%. Histopathological discordance was observed in 6.5% (19/292) of lesions, including overall underestimation in 4.4% (13/292) and false negatives in 2% (6/292). Of the 6 false-negative cases, 2 were identified at immediate radiologic-pathologic concordance assessment and 4 during post-biopsy MRI follow-up at 7, 21, 35, and 36 months. On multivariable analysis, lesion location outside the outer quadrants was significantly associated with discordance (OR = 3.02; 95% CI, 1.09-9.79; p = 0.044). Lesion size ≥2 cm showed a nonsignificant trend toward higher odds of discordance (OR = 2.65; 95% CI, 0.96-7.01; p = 0.053).

CONCLUSIONS: MRI-VABB is a reliable technique for evaluating breast lesions detected only on MRI. However, histopathological underestimation and false positives may still occur, particularly in lesions located outside the outer quadrants. Careful radiologic-pathologic concordance assessment and appropriate follow-up after benign biopsy results are essential to optimize patient management.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Achrafi, Diallo, Henrot, et al. MRI-Guided Vacuum-Assisted Breast Biopsy for MRI-Only Breast Lesions: Diagnostic Performance and Predictors of Histopathological Discordances. Acad Radiol. 2026. PMID: 42624733. doi:10.1016/j.acra.2026.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。